loadpatents
name:-0.020482063293457
name:-0.011361122131348
name:-0.0059070587158203
MCKENNA; Jeffrey Patent Filings

MCKENNA; Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for MCKENNA; Jeffrey.The latest application filed is for "combination therapy for the treatment of cancer".

Company Profile
5.14.25
  • MCKENNA; Jeffrey - Carlisle MA
  • McKenna; Jeffrey - Cambridge MA
  • McKenna; Jeffrey - Horsham GB
  • McKenna; Jeffrey - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination Therapy For The Treatment Of Cancer
App 20220211815 - KOPP; Nadja ;   et al.
2022-07-07
Covalent Targeting Of E3 Ligases
App 20210369731 - Spradlin; Jessica ;   et al.
2021-12-02
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
Grant 11,098,077 - Kanne , et al. August 24, 2
2021-08-24
Bis 2'-5'-RR-(3'F-A)(3'F-A) cyclic dinucleotide compound and uses thereof
Grant 10,975,114 - Leong , et al. April 13, 2
2021-04-13
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
Grant 10,906,930 - Katibah , et al. February 2, 2
2021-02-02
Bis 2'-5'-rr-(3'f-a)(3'f-a) Cyclic Dinucleotide Compound And Uses Thereof
App 20200199169 - LEONG; Justin ;   et al.
2020-06-25
Locked Nucleic Acid Cyclic Dinucleotide Compounds And Uses Thereof
App 20190185511 - KANNE; David Braun ;   et al.
2019-06-20
Compositions And Methods For Activating "stimulator Of Interferon Gene"-dependent Signalling
App 20190062365 - KATIBAH; George Edwin ;   et al.
2019-02-28
Autotaxin inhibitors
Grant 10,183,025 - Beattie , et al. Ja
2019-01-22
Autotaxin Inhibitors
App 20180021345 - BEATTIE; David ;   et al.
2018-01-25
Autotaxin inhibitors
Grant 9,763,957 - Beattie , et al. September 19, 2
2017-09-19
Autotaxin Inhibitors
App 20160184318 - BEATTIE; David ;   et al.
2016-06-30
Autotaxin Inhibitors
App 20160168119 - BAETTIG; Urs ;   et al.
2016-06-16
Tricyclic compounds for inhibiting the CFTR channel
Grant 9,359,381 - Ahmed , et al. June 7, 2
2016-06-07
Substituted pyrazino[1',2':1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4',5':3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel
Grant 9,303,035 - Ahmed , et al. April 5, 2
2016-04-05
Tricyclic Compounds For Inhibiting The Cftr Channel
App 20150336986 - AHMED; Mahbub ;   et al.
2015-11-26
Tricyclic Compounds
App 20140171412 - AHMED; Mahbub ;   et al.
2014-06-19
Tricyclic Compounds
App 20140171417 - AHMED; Mahbub ;   et al.
2014-06-19
3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists
App 20130331369 - Ambarkhane; Ameet Vijay ;   et al.
2013-12-12
3-spirocyclic piperidine derivatives as ghrelin receptor agonists
Grant 8,546,416 - Ambarkhane , et al. October 1, 2
2013-10-01
3-spirocyclic Piperidine Derivatives As Ghrelin Receptor Agonists
App 20120302540 - Ambarkhane; Ameet Vijay ;   et al.
2012-11-29
Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
App 20120295942 - Devereux; Nicholas James ;   et al.
2012-11-22
Pyrazolo[5,1b]oxazole derivatives as CRF-.sub.1 receptor antagonists
Grant 8,163,785 - Devereux , et al. April 24, 2
2012-04-24
Cyclohexyl Amide Derivatives As Crf Receptor Antagonists
App 20110201629 - Atkinson; Benjamin ;   et al.
2011-08-18
Organic compounds
Grant 7,994,203 - Bruce , et al. August 9, 2
2011-08-09
Pyrazolo[5,1b]oxazole Derivatives As Crf-1 Receptor Antagonists
App 20110190360 - Devereux; Nicholas James ;   et al.
2011-08-04
Pyrazole Pyrazine Amine Compounds As Kinase Inhibitors, Compositions Thereof And Methods Of Treatment Therewith
App 20090270418 - Sloss; Marianne ;   et al.
2009-10-29
Compounds useful for the treatment of cancer, compositions thereof and methods therewith
App 20060142352 - McKenna; Jeffrey ;   et al.
2006-06-29
Compounds useful for the treatment of cancer, compositions thereof and methods therewith
Grant 7,037,936 - McKenna , et al. May 2, 2
2006-05-02
Compounds Useful For The Treatment Of Cancer, Compositions Thereof And Methods Therewith
App 20060030617 - McKenna; Jeffrey ;   et al.
2006-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed